COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,284 Articles (22,759 medRxiv, 8,525 bioRxiv)

Most recent first Previous |  Page 161: Articles 1601-1610  | Next

Design of nanobody targeting SARS-CoV-2 spike glycoprotein using CDR-grafting assisted by molecular simulation and machine learning
Ferraz, M. V. F., Adan, W. C. S., Lima, T. E., Santos, A. J. C., de Paula, S. O., Dhalia, R., Wallau, G. L., Wade, R. C., Viana, I. F. T., Lins, R. D.
10.1101/2024.09.30.615772 — Posted: 2024-10-01
SARS-CoV-2 Omicron XBB infections boost cross-variant neutralizing antibodies, potentially explaining the observed delay of the JN.1 wave in some Brazilian regions
Tort, L. F., de Araujo, M. F., Arantes, I., MARTINS, J. S., Gomes, M. F., de Carvalho, F. C., de Almeida, W. A., Caetano, B. C., Appolinario, L. R., Pereira, E. C., Carvalho, J. G., Miyajima, F. F. C., Wallau, G. L., Naveca, F. G., Alves, P., Espindola, O., Brasil, P., Resende, P. C., Bello, G., Siqueira, M. M.
10.1101/2024.09.28.24314453 — Posted: 2024-09-30
Gut colonization of Enterococcus species is associated with COVID-19 disease in Uganda
Agudelo, C., Kateete, D. P., Nasinghe, E., Kamulegeya, R., Lubega, C., Mbabazi, M. M., Baker, N., Lin, K., Liu, C. C., Kasambula, A. S., Kigozi, E., Komakech, K., Mukisa, J., Mulumba, K., Mwachan, P., Nakalanda, B. S., Nalubega, G. P., Nsubuga, J., Sitenda, D., Ssenfuka, H., Cirolia, G., Gustafson, J. T., Wang, R., Nsubuga, M. L., Yiga, F., Stanley, S. A., Bagaya, B. S., Elliott, A., Joloba, M., Wolf, A. R.
10.1101/2024.09.28.24314457 — Posted: 2024-09-30
Predicting Mobile Health Clinic Utilization for COVID-19 Vaccination in South Carolina: A Statistical Framework for Strategic Resource Allocation
Gezer, F., Howard, K. A., Bennett, K. J., Litwin, A. H., Sease, K. K., Rennert, L.
10.1101/2024.09.27.24314475 — Posted: 2024-09-29
Common pathogenic mechanisms for COVID-19 and differentiated thyroid cancer: a proteomic analysis
Liu, H., Wang, J., Yang, D., Chen, C.
10.1101/2024.09.28.24314528 — Posted: 2024-09-29
Comparative evaluation of cell-based assay technologies for scoring drug-induced condensation of SARS-CoV-2 nucleocapsid protein
Quek, R. T., Shirazinejad, C. R., Young, C. L., Hardy, K. S., Lim, S., Elms, P. J., McSwiggen, D. T., Mitchison, T. J., Silver, P. A.
10.1101/2024.09.26.615262 — Posted: 2024-09-28
The post-pandemic hospital and mortality burden of COVID-19 compared with influenza: A national cohort study in Denmark, May 2022 to June 2024
Bager, P., Bech Svalgaard, I., Kristensen Lomholt, F., Emborg, H.-D., Engbo Christiansen, L., Soborg, B., Hviid, A., Skafte Vestergaard, L.
10.1101/2024.09.26.24314428 — Posted: 2024-09-27
Cost-effectiveness analysis of COVID-19 mRNA XBB.1.5 Fall 2023 vaccination in the Netherlands
Zeevat, F., van der Pol, S., Westra, T., Beck, E., Postma, M. J., Boersma, C.
10.1101/2024.09.26.24314420 — Posted: 2024-09-27
The impact of the COVID-19 pandemic on mental health care utilization among people living with HIV: A real-world data study
Pasha, A., Qiao, S., Zhang, J., Cai, R., He, B., Yang, X., Liang, C., Weissman, S., Li, X.
10.1101/2024.09.26.24314443 — Posted: 2024-09-27
The coronavirus nsp14 exoribonuclease interface with the cofactor nsp10 is essential for efficient virus replication and enzymatic activity.
Grimes, S. L., Heaton, B. E., Anderson, M. L., Burke, K. N., Stevens, L. J., Lu, X., Heaton, N. S., Denison, M. R., Anderson-Daniels, J.
10.1101/2024.09.26.615217 — Posted: 2024-09-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).